Search

Displaying results 8311 - 8320 of 10000 in total
  1. Drug

    Flezurafenib

    go.drugbank.com/drugs/DB21725
    Experimental

    Flezurafenib has a monoisotopic molecular weight of 456.16 Da. … Flezurafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Flezurafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.

  2. Drug

    Ocadusertib

    go.drugbank.com/drugs/DB21732
    Investigational

    Ocadusertib is a small molecule drug. The usage of the INN stem '-sertib' in the name indicates that Ocadusertib is a serine/threonine kinase inhibitor. … Ocadusertib has a monoisotopic molecular weight of 459.19 Da.

  3. Drug

    Teprosulvose

    go.drugbank.com/drugs/DB21738
    Experimental

    Teprosulvose is a small molecule drug. Teprosulvose has a monoisotopic molecular weight of 568.33 Da.

  4. Drug

    Zeprumetostat

    go.drugbank.com/drugs/DB21740
    Investigational

    Zeprumetostat is a small molecule drug. The usage of the INN stem '-metostat' in the name indicates that Zeprumetostat is a histone N-methyltransferase inhibitor. … Zeprumetostat has a monoisotopic molecular weight of 548.34 Da.

  5. Drug

    Suvadronabinol

    go.drugbank.com/drugs/DB21741
    Experimental

    Suvadronabinol is a small molecule drug. Suvadronabinol has a monoisotopic molecular weight of 513.31 Da.

  6. Drug

    Pregabalin naproxencarbil

    go.drugbank.com/drugs/DB21744
    Experimental

    Pregabalin naproxencarbil is a small molecule drug. Pregabalin naproxencarbil has a monoisotopic molecular weight of 459.23 Da.

  7. Drug

    Dexfadrostat

    go.drugbank.com/drugs/DB21746
    Investigational

    Dexfadrostat is under investigation in clinical trial NCT04007406 (DP13 - a Phase II Study in Patients With Primary Aldosteronism).

    Synonyms: Fadrozole, (r)-
  8. Drug

    Azilsartan

    go.drugbank.com/drugs/DB21772
    Investigational

    Categories: Angiotensin 2 Receptor Blocker, Heterocyclic Compounds, 1-Ring
  9. Drug

    Milsaperidone

    go.drugbank.com/drugs/DB24348
    ApprovedInvestigational

    [L56056] On February 20, 2026, milsaperidone was approved by the FDA for the treatment of Bipolar I Disorder and schizophrenia.[L56059] … [A275426, A202004] Similarly, milsaperidone acts as an antagonist at dopamine D2 and 5-HT2A receptors,[A275427] as well as other adrenergic, dopamine, and serotonin receptor subtypes.

    Synonyms: (S)-Hydroxy iloperidoneCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
  10. Drug

    LX-623

    go.drugbank.com/drugs/DB33571
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring